ArticleRadiological physics and technology2025
Quantitative evaluation of entrance skin dose from kV imaging in respiratory motion-tracking radiotherapy.
Article in Radiological physics and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although some studies have reported the radiation doses associated with kilovoltage (kV) X-ray imaging in motion-tracking radiotherapy using Radixact Synchrony, detailed assessments of skin doses that reflect the actual imaging frequency and patient positioning remain insufficient. This study aimed to estimate the entrance skin dose (ESD) associated with frequent kV image acquisition, evaluate the radiation dose in past patients at our hospital, and identify the contribution of imaging dose relative to the prescription dose and dose constraints. For each protocol available on the Radixact Synchrony system, the half-value layer, X-ray tube voltage, and air kerma at the kV imaging isocenter were measured using a semiconductor detector (RaySafe X2, Unfors RaySafe AB, Sweden). The ESD associated with the kV image acquisition was estimated based on the number of kV image acquisitions during tracking and corresponding imaging angles from 109 patients who underwent motion-tracking radiotherapy. The total number of imaging exposures throughout the treatment period averaged 1230 per patient, with a maximum of 3750. The cumulative ESD per acquisition angle averaged 69.1 mGy, with a maximum of 367.2 mGy. Furthermore, by considering the overlap of imaging angles and the influence of transmitted X-rays, the estimated maximum skin dose was 951.9 mGy. In this case, the maximum skin dose in the treatment plan was 47.9 Gy, and so the imaging dose corresponded to approximately 2% of the prescribed skin dose. Our findings indicate that the contribution of the imaging dose to the treatment dose is sufficiently low.
Indexed as
Identifiers
41075116What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.